首页> 外文期刊>European journal of gastroenterology and hepatology >Clinical significance of a scoring formula of liver injury for the preoperative evaluation of patients with liver cirrhosis
【24h】

Clinical significance of a scoring formula of liver injury for the preoperative evaluation of patients with liver cirrhosis

机译:肝损伤评分公式对肝硬化患者术前评估的临床意义

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective: The aim of this study was to establish a clinical scoring formula of liver injury (SFLI) using the matter element analysis method, in order to provide the necessary information for the preoperative assessment and treatment of liver cirrhosis in clinical practice. Materials and Methods: We collected preoperative information for 12 serum biochemical markers (ALB, PA, TBil, SCr, INR, ALT, AST, γ-GT, ALP, PT, APTT, and TT) from patients with liver cirrhosis, statistically analyzed the relationship between the serum biochemical markers and the extent of liver injury, and obtained the liver injury scoring formula using the matter element analysis method. Results: In our formula, the serum biochemical markers of patients with different degrees of liver cirrhosis damage led to different R-values, which represented the severity of the disease and the liver functional reserve. R=1 indicates that the liver tissue is normal; 0.770≤R<1 indicates that the liver is in the early stage of cirrhosis (SFLI I stage); 0.712≤R<0.770 indicates that the liver is in the intermediate state of compensated cirrhosis and decompensated cirrhosis (SFLI I+ stage); 0.629≤R<0.712 indicates that the liver is in the decompensated cirrhosis stage with ascites (SFLI II stage); 0.401≤R<0.629 indicates that the liver is in the stage of severely decompensated cirrhosis with ascites, and patients present with varying degrees of hepatic encephalopathy, hepatic coma, and other complications. Conclusion: The SFLI that we constructed can sensitively and accurately reflect the conditions of liver cirrhosis damage and liver functional reserve.
机译:目的:本研究旨在利用物元分析法建立肝损伤的临床评分公式,为临床实践中肝硬化的术前评估和治疗提供必要的信息。材料和方法:我们从肝硬化患者中收集了12种血清生化指标(ALB,PA,TBil,SCr,INR,ALT,AST,γ-GT,ALP,PT,APTT和TT)的术前信息,对血清生化指标与肝损伤程度的关系,并采用物元分析法获得肝损伤评分公式。结果:在我们的公式中,具有不同程度肝硬化损害的患者的血清生化标志物导致了不同的R值,代表了疾病的严重程度和肝功能储​​备。 R = 1表示肝组织正常; 0.770≤R<1表示肝脏处于肝硬化的早期阶段(SFLI I阶段); 0.712≤R<0.770表示肝脏处于代偿性肝硬化和代偿性肝硬化的中间状态(SFLI I +期); 0.629≤R<0.712表示肝处于腹水失代偿性肝硬化阶段(SFLI II阶段); 0.401≤R<0.629表示肝处于腹水严重失代偿性肝硬化阶段,患者出现不同程度的肝性脑病,肝昏迷和其他并发症。结论:我们构建的SFLI可以灵敏,准确地反映肝硬化损害状况和肝功能储​​备情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号